Fingerprint
Dive into the research topics of 'Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically